We are live on ! Find out more
BDTX icon

Black Diamond Therapeutics

88 hedge funds and large institutions have $717M invested in Black Diamond Therapeutics in 2020 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 18

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

10% more funds holding

Funds holding: 8088 (+8)

1.75% more ownership

Funds ownership: 64.43%66.17% (+1.7%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

26% less capital invested

Capital invested by funds: $968M → $717M (-$251M)

Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
1.78%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
19
Increased
38
Reduced
18
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VC
26
Vivo Capital
California
$4.4M -$150K -4,932 -3%
Adage Capital Partners
27
Adage Capital Partners
Massachusetts
$4.38M +$4.41M +145,000 New
LGM
28
Logos Global Management
California
$3.73M
Charles Schwab
29
Charles Schwab
California
$3.22M +$770K +25,314 +31%
Norges Bank
30
Norges Bank
Norway
$3.02M
ACH
31
ArrowMark Colorado Holdings
Colorado
$2.12M
N
32
Nuveen
North Carolina
$1.98M +$500K +16,426 +33%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.77M +$368K +12,076 +26%
Allianz Asset Management
34
Allianz Asset Management
Germany
$1.54M +$922K +30,309 +147%
SG Americas Securities
35
SG Americas Securities
New York
$1.52M +$1.31M +42,884 +576%
BFM
36
Boothbay Fund Management
New York
$1.3M +$634K +20,846 +95%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.13M +$313K +10,276 +38%
Bank of America
38
Bank of America
North Carolina
$879K +$523K +17,182 +145%
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$827K +$275K +9,022 +49%
T. Rowe Price Associates
40
T. Rowe Price Associates
Maryland
$817K +$823K +27,028 New
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$742K +$717K +23,546 +2,355%
Macquarie Group
42
Macquarie Group
Australia
$715K +$711K +23,371 +9,165%
Prudential Financial
43
Prudential Financial
New Jersey
$639K +$5.48K +180 +0.9%
Swiss National Bank
44
Swiss National Bank
Switzerland
$605K
State of Wisconsin Investment Board
45
State of Wisconsin Investment Board
Wisconsin
$562K
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$514K +$57.2K +1,879 +12%
TC
47
Telemus Capital
Michigan
$506K +$152K +5,000 +50%
FAM
48
Fred Alger Management
New York
$502K -$225K -7,383 -31%
HS
49
HighVista Strategies
Massachusetts
$496K +$499K +16,391 New
AllianceBernstein
50
AllianceBernstein
Tennessee
$432K -$24.3K -800 -5%

BDTX Hedge Fund Activity: Q3 2020 in Review

88 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Black Diamond Therapeutics (BDTX) for Q3 2020, worth a combined $717M — down 26% from $968M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BDTX positions and 11 closed out — a net gain of 8 holders — while 38 added to existing stakes and 18 trimmed.

The largest buyer was Vanguard Group, adding an estimated $24M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $44M sold.

  • 88 institutional investors held Black Diamond Therapeutics (BDTX) as of Q3 2020, up from 80 in Q2 2020.
  • Funds reported $717M of Black Diamond Therapeutics stock for Q3 2020, down 26% quarter-over-quarter.
  • 19 funds opened new Black Diamond Therapeutics positions in Q3 2020 and 11 closed out, a net change of +8 holders.
  • The largest Black Diamond Therapeutics buyer in Q3 2020 was Vanguard Group, an estimated $24M added.
  • The largest Black Diamond Therapeutics seller in Q3 2020 was Perceptive Advisors, an estimated $44M sold.

Based on aggregated 13F filings for Q3 2020.